Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET).

Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET).

In the era of somatostatin analogues and targeted therapies, the role of chemotherapy in NET remains largely undefined. This systematic review aimed to assess the effect of chemotherapy on response rates (RR), progression-free survival (PFS), overall survival (OS) and toxicity compared to other chem...

Full description

Bibliographic Details
Main Authors:	Matthew H Wong, David L Chan, Adrian Lee, Bob T Li, Sumit Lumba, Stephen J Clarke, Jaswinder Samra, Nick Pavlakis
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4928873?pdf=render

Similar Items

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy
by: Sumit Sahni, et al.
Published: (2020-03-01)

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
by: Bongiovanni A, et al.
Published: (2015-12-01)

Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature.
by: David L Chan, et al.
Published: (2015-01-01)

Correction: Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature.
by: David L Chan, et al.
Published: (2015-01-01)

Everolimus in the management of metastatic neuroendocrine tumours
by: David L. Chan, et al.
Published: (2017-01-01)

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
by: Ma Yue, et al.
Published: (2011-03-01)

A pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) (NET and undifferentiated carcinoma of the pancreas with osteoclast-like giant cells) with metastatic neuroendocrine component to the liver
by: Guofeng Gao, et al.
Published: (2021-01-01)

The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events
by: Meredith Cummins, et al.
Published: (2013-09-01)

Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)
by: Vera G. Megdanova-Chipeva, et al.
Published: (2020-07-01)

Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
by: Inbal Uri, et al.
Published: (2018-07-01)

Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis
by: Hong-Chen Qu, et al.
Published: (2020-01-01)

Osteoclast inhibitors to prevent bone metastases in men with high-risk, non-metastatic prostate cancer: A systematic review and meta-analysis.
by: Aimee R Hayes, et al.
Published: (2018-01-01)

Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice
by: Bob T. Li, et al.
Published: (2014-01-01)

Does induction chemotherapy advance the multimodal treatment of locally advanced esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation?
by: Merrill S Kies
Published: (2020-01-01)

MULTIDISCIPLINARY MANAGEMENT OF METASTATIC NEUROENDOCRINE TUMOURS
by: Majid Ali, et al.
Published: (2017-07-01)

An Extremely Rare Case of Advanced Metastatic Small Cell Neuroendocrine Carcinoma of Sinonasal Tract
by: Yu Yu Thar, et al.
Published: (2016-01-01)

Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma)
by: Sakura Hiraide, et al.
Published: (2017-05-01)

New drug developments in metastatic gastric cancer
by: Aaron C. Tan, et al.
Published: (2018-11-01)

Treatments for patients with advanced neuroendocrine tumors: a network meta-analysis
by: Tingting Liu, et al.
Published: (2019-05-01)

Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance
by: Beatriz Soldevilla, et al.
Published: (2021-05-01)

Diagnosis and Management of Rectal Neuroendocrine Tumors (NETs)
by: Francesco Maione, et al.
Published: (2021-04-01)

Metastatic neuroendocrine tumor masquerading as liver abscesses
by: Abhimanyu Aggarwal, et al.
Published: (2020-12-01)

Metastatic primary neuroendocrine carcinoma of the breast (NECB)
by: Tsung-Hsien Tsai, et al.
Published: (2018-03-01)

Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment Stratification.
by: Sebastian Krug, et al.
Published: (2015-01-01)

The Quality of Online Information for an Uncommon Malignancy—Neuroendocrine Tumours (NETs)
by: Safa Sohail, et al.
Published: (2021-02-01)

Possibilities of palliative chemotherapy in patients with locally advanced and metastatic pancreatic cancer
by: L. I. Moskvicheva, et al.
Published: (2020-12-01)

Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
by: Josef Gillson, et al.
Published: (2020-05-01)

Multivisceral resection of pancreatic neuroendocrine tumours: a report of two cases
by: Hugh Thomas J, et al.
Published: (2011-08-01)

Different Chemotherapy Regimens in the Management of Advanced or Metastatic Urothelial Cancer: a Bayesian Network Meta-Analysis of Randomized Controlled Trials
by: Yi Wang, et al.
Published: (2018-10-01)

Mass Cytometry Reveals a Sustained Reduction in CD16+ Natural Killer Cells Following Chemotherapy in Colorectal Cancer Patients
by: Diana Shinko, et al.
Published: (2019-11-01)

Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
by: Bryan Oronsky, et al.
Published: (2017-12-01)

Hepatic Arterial Embolization for the Treatment of Metastatic Neuroendocrine Tumors
by: Eric Lee, et al.
Published: (2012-01-01)

Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine Tumors
by: Véronique Debien, et al.
Published: (2021-06-01)

Neuroendocrine metastatic tumors of the liver resembling hepatocellular carcinoma
by: Julián Arista-Nasr, MD, et al.
Published: (2010-04-01)

Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival
by: S. Rudisile, et al.
Published: (2019-08-01)

Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis
by: Alberto Bongiovanni, et al.
Published: (2020-04-01)

Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer
by: Qi Zhao, et al.
Published: (2021-06-01)

Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration
by: Eva Segelov, et al.
Published: (2017-08-01)

Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation)
by: Vijay M. Patil, et al.
Published: (2016-01-01)

The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis.
by: Yangyang Liu, et al.
Published: (2017-01-01)